Aurora Cannabis Inc [ACB] stock is trading at $4.6, down -0.43%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ACB shares have gain 3.60% over the last week, with a monthly amount glided 3.84%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Canaccord Genuity upgraded its rating to Buy on February 09, 2024. On September 21, 2022, upgrade upgraded it’s rating to Hold. Cantor Fitzgerald upgraded its rating to a Overweight. Stifel upgraded its rating to a Hold. MKM Partners upgraded its rating to Neutral for this stock on September 28, 2021. In a note dated September 03, 2021, Jefferies upgraded an Hold rating on this stock and revised its target price from $7.49 to $6.78.
Aurora Cannabis Inc [ACB] stock has fluctuated between $3.42 and $7.20 over the past year. Currently, Wall Street analysts expect the stock to reach $5.92 within the next 12 months. Aurora Cannabis Inc [NASDAQ: ACB] shares were valued at $4.6 at the most recent close of the market. An investor can expect a potential return of 28.7% based on the average ACB price forecast.
Analyzing the ACB fundamentals
Aurora Cannabis Inc [NASDAQ:ACB] reported sales of 246.62M for the trailing twelve months, which represents a growth of 26.24%. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at 0.01%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.0%. To continue investigating profitability, this company’s Return on Assets is posted at 0.0, Equity is 0.0 and Total Capital is 0.01. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Aurora Cannabis Inc’s Current Ratio is 4.31. Further, the Quick Ratio stands at 2.16, while the Cash Ratio is 1.24. Considering the valuation of this stock, the price to sales ratio is 1.05, the price to book ratio is 0.66 and price to earnings (TTM) ratio is 97.05.
